Literature DB >> 16723993

The power and the promise of oncogene-induced senescence markers.

Manuel Collado1, Manuel Serrano.   

Abstract

Recently, it has been shown that oncogene-induced senescence (OIS) occurs during the early stages of tumorigenesis. Senescent tumour cells are abundant within premalignant neoplastic lesions, whereas they are scarce in malignant tumours. This association of senescence with the premalignant stages of tumour progression opens the possibility of using senescence markers as diagnostic and prognostic tools. Moreover, some chemotherapeutic protocols induce senescence in tumour cells and, consequently, senescence markers could help to monitor treatment response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16723993     DOI: 10.1038/nrc1884

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  159 in total

1.  PRAK suppresses oncogenic ras-induced hematopoietic cancer development by antagonizing the JNK pathway.

Authors:  Naoto Yoshizuka; Maoyi Lai; Rong Liao; Ryan Cook; Changchun Xiao; Jiahuai Han; Peiqing Sun
Journal:  Mol Cancer Res       Date:  2012-06-04       Impact factor: 5.852

Review 2.  Bypassing cellular senescence by genetic screening tools.

Authors:  Mar Vergel; Amancio Carnero
Journal:  Clin Transl Oncol       Date:  2010-06       Impact factor: 3.405

Review 3.  [Malignancy potential of precursor lesions: determination using molecular markers].

Authors:  A Jung
Journal:  Pathologe       Date:  2011-11       Impact factor: 1.011

4.  The general transcription factor TAF7 is essential for embryonic development but not essential for the survival or differentiation of mature T cells.

Authors:  Anne Gegonne; Xuguang Tai; Jinghui Zhang; Gang Wu; Jianjian Zhu; Aki Yoshimoto; Jeffrey Hanson; Constance Cultraro; Qing-Rong Chen; Terry Guinter; Zhihui Yang; Karen Hathcock; Alfred Singer; Jaime Rodriguez-Canales; Lino Tessarollo; Susan Mackem; Daoud Meerzaman; Ken Buetow; Dinah S Singer
Journal:  Mol Cell Biol       Date:  2012-03-12       Impact factor: 4.272

5.  [R248C FGFR3 mutation. Effect on cell growth, apoptosis and attachment in HaCaT keratinocytes].

Authors:  C Hafner; A Hartmann
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

Review 6.  Pathways of oncogene-induced senescence in human melanocytic cells.

Authors:  Rajat Bansal; Mikhail A Nikiforov
Journal:  Cell Cycle       Date:  2010-07-03       Impact factor: 4.534

Review 7.  Inflammatory networks during cellular senescence: causes and consequences.

Authors:  Adam Freund; Arturo V Orjalo; Pierre-Yves Desprez; Judith Campisi
Journal:  Trends Mol Med       Date:  2010-05-03       Impact factor: 11.951

Review 8.  Epigenetic control of aging.

Authors:  Ursula Muñoz-Najar; John M Sedivy
Journal:  Antioxid Redox Signal       Date:  2010-11-22       Impact factor: 8.401

9.  Stiffening of human skin fibroblasts with age.

Authors:  Christian Schulze; Franziska Wetzel; Thomas Kueper; Anke Malsen; Gesa Muhr; Soeren Jaspers; Thomas Blatt; Klaus-Peter Wittern; Horst Wenck; Josef A Käs
Journal:  Biophys J       Date:  2010-10-20       Impact factor: 4.033

10.  SIRT1 is required for oncogenic transformation of neural stem cells and for the survival of "cancer cells with neural stemness" in a p53-dependent manner.

Authors:  Ji-Seon Lee; Jeong-Rak Park; Ok-Seon Kwon; Tae-Hee Lee; Ichiro Nakano; Hiroyuki Miyoshi; Kwang-Hoon Chun; Myung-Jin Park; Hong Jun Lee; Seung U Kim; Hyuk-Jin Cha
Journal:  Neuro Oncol       Date:  2014-08-05       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.